Edward Chung
Vice President, Investor Relations
Replay available
Bio-Rad Laboratories, Inc. (BIO) Q4 2025 Earnings Call
Bio-Rad Laboratories, Inc. (NYSE: BIO) Q4 2025 earnings conference call, held 2026-02-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
John DiVincenzo
President and Chief Operating Officer
Rup Lakharaju
Executive Vice President and Chief Financial Officer
Norman Schwartz
Chief Executive Officer
Jack Meehan
Analyst, Nefron
Dan Leonard
Analyst, UBS
Tycho Peterson
Analyst, Jefferies
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Bio-rad Laboratories, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:02.374 Please stand by. Good 00:00:02.374 -- 00:00:07.480 day, everyone, and welcome to the Bio-Rad fourth quarter and full year 2025 results conference 00:00:07.480 -- 00:00:10.544 call. At this time, I would like to hand things over to Mr. 00:00:10.544 -- 00:00:13.647 Edward Chung. Please go ahead, sir. 00:00:13.647 -- 00:00:16.090 Good afternoon, everyone. Thank you for joining us. 00:00:16.090 -- 00:00:21.837 Today, we will review the fourth quarter and full year 2025 financial results 00:00:21.837 -- 00:00:25.361 and provide an update on key business trends for Bio-Rad. 00:00:25.361 -- 00:00:30.866 With me on the call today are Norman Schwartz, our Chief Executive Officer, John DiVincenzo, 00:00:30.866 -- 00:00:36.214 President and Chief Operating Officer, and Rup Lakharaju, Executive Vice President 00:00:36.214 -- 00:00:41.260 and Chief Financial Officer. Before we begin our review, I would like to remind everyone 00:00:41.260 -- 00:00:45.386 that we will be making forward-looking statements about management's goals, plans and 00:00:45.386 -- 00:00:49.791 expectations, our future financial performance, and other matters. 00:00:49.791 -- 00:00:53.797 These statements are based on assumptions and expectations of future events that are 00:00:53.797 -- 00:00:58.411 subject to risks and uncertainties. Our actual results may differ materially from these 00:00:58.411 -- 00:01:01.315 plans, goals, and expectations. 00:01:01.315 -- 00:01:05.661 You should not place undue reliance on these forward-looking statements, and I encourage 00:01:05.661 -- 00:01:10.387 you to review our filings for the SEC, where we discuss in detail the risk factors in 00:01:10.387 -- 00:01:15.073 our business. The company does not intend to update any forward-looki...